Rossari Biotech Ltd
About
[
edit
]
Rossari Biotech was started in 2003.They are engaged in chemical manufacturing with a focus on specialty chemicals industry.
[
add key points
]
- Market Cap ₹ 5,290 Cr.
- Current Price ₹ 1,019
- High / Low ₹ 1,147 / 664
- Stock P/E 72.6
- Book Value ₹ 70.0
- Dividend Yield 0.00 %
- ROCE 37.5 %
- ROE 31.8 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Stock is trading at 14.55 times its book value
Loading peers table ...
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
---|---|---|---|---|---|---|---|
128 | 150 | 162 | 160 | 109 | 172 | 210 | |
106 | 122 | 133 | 136 | 86 | 142 | 176 | |
Operating Profit | 22 | 28 | 30 | 24 | 24 | 30 | 34 |
OPM % | 17% | 19% | 18% | 15% | 22% | 18% | 16% |
Other Income | 1 | 1 | 0 | 2 | 2 | 4 | 1 |
Interest | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
Depreciation | 4 | 4 | 4 | 5 | 4 | 6 | 6 |
Profit before tax | 19 | 24 | 25 | 20 | 21 | 28 | 28 |
Tax % | 26% | 25% | 26% | 26% | 25% | 25% | 24% |
Net Profit | 14 | 18 | 18 | 15 | 15 | 21 | 22 |
EPS in Rs | 3.99 | 4.16 | |||||
Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|
516 | 600 | 651 | |
438 | 495 | 539 | |
Operating Profit | 78 | 105 | 112 |
OPM % | 15% | 17% | 17% |
Other Income | 1 | 4 | 9 |
Interest | 3 | 4 | 3 |
Depreciation | 12 | 17 | 20 |
Profit before tax | 63 | 88 | 97 |
Tax % | 28% | 26% | |
Net Profit | 46 | 65 | 73 |
EPS in Rs | |||
Dividend Payout % | 0% | 4% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 16% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 42% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 32% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|
4 | 10 | 10 | |
Reserves | 119 | 277 | 353 |
Borrowings | 8 | 70 | 0 |
118 | 115 | 123 | |
Total Liabilities | 250 | 471 | 487 |
74 | 94 | 136 | |
CWIP | 3 | 22 | 30 |
Investments | 0 | 18 | 0 |
173 | 338 | 321 | |
Total Assets | 250 | 471 | 487 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | |
---|---|---|
71 | 55 | |
-37 | -188 | |
-29 | 157 | |
Net Cash Flow | 5 | 23 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | |
---|---|---|
ROCE % | 37% | |
Debtor Days | 61 | 57 |
Inventory Turnover | 6.61 |
Documents
Add documentRecent announcements
- Clarification With Respect To Increase In Volume 22 Feb
- Clarification With Respect To Increase In Volume 22 Feb
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 3 Feb
- Announcement under Regulation 30 (LODR)-Newspaper Publication 25 Jan
- Announcement under Regulation 30 (LODR)-Press Release / Media Release 23 Jan
View all